According to a report in Bloomberg, the ‘Spravato’ nasal spray was used by 6,000 people with anti -treatment depression after receiving the approval as prescribed in March 2019. People are suffering from a major depression disorder.
According to the study, volunteers who received nasal sprays marked a rapid decrease in the severity of their thoughts, although the results were not different in the way of statistical significance from the patients used. placebo.
